Bombers and Sundowner are both right. Sales and reach is looking good and I really think they are onto something now they are part of the Covid testing market. However, for every dollar of revenue they improve each year they find a way to spend it long before appearing back in shareholders hands. The next quarter, if you can believe their rhetoric, should be cash flow positive - then and I only then will I be convinced we have turned the corner. I said at 10c RNO was a buy - until we are cash flow positive (or announce more deals supporting that we will be) I think the 20c range is a hold and RNO is fairly valued in this range - hence my change of sentiment.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Bombers and Sundowner are both right. Sales and reach is looking...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online